子宮內避孕器市場規模、佔有率和成長分析（按類型、年齡層和地區）：產業預測（2024-2031）

2022年全球子宮內避孕器市場規模估值為31.2億美元，從2023年的32.3億美元成長到2031年的43.6億美元，預測期（2024-2031年）複合年成長率預計將成長3.8%。

由於意外懷孕、不安全墮胎率上升以及人們對避孕選擇的認知不斷增強，子宮內避孕器 (IUD) 市場正在顯著成長。為了滿足這項需求，政府的措施和研發進步正在推動創新子宮內避孕器的誕生。在美國，隨著政府努力改善獲得性健康和生殖健康服務的機會，計劃晚孕的趨勢補充了這一成長趨勢。然而，缺乏對子宮內避孕器的認知、潛在的副作用以及過早取出等挑戰正在阻礙市場的擴張。儘管存在這些障礙，新興經濟體可支配收入的增加和對健康生活方式不斷成長的需求為市場相關人員提供了充滿希望的機會。持續的技術創新和監管支援預計將進一步推動市場成長。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資來源
• 市場生態系統
• 市場魅力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究

全球子宮內避孕器市場規模和複合年成長率：按類型（2024-2031）

• 非荷爾蒙：含銅子宮內避孕器
• 荷爾蒙：釋放黃體素的子宮內避孕器

全球子宮內避孕器市場規模與複合年成長率：按年齡層別分類（2024-2031）

• 25-34歲
• 35-44歲
• 44歲以上
• 15-24歲

全球子宮內避孕器市場規模及複合年成長率：按分銷管道分類（2024-2031）

• 醫院
• 婦科門診
• 社區健康服務中心
• 其他

全球子宮內避孕器市場規模和複合年成長率：按最終用戶分類（2024-2031）

• 醫院
• 診所
• 區域醫療中心
• 其他

全球子宮內避孕器市場規模及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2023年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• AbbVie Inc.
• Bayer AG
• CooperSurgical Inc.
• DKT International
• EUROGINE, SL
• Mona Lisa NV
• OCON Medical Ltd.
• Pregna International Limited.
• Prosan International BV
• SMB Corporation of India
• Teva Pharmaceuticals
• ANI Pharmaceuticals
• Mylan NV (Viatris)
• Melbea AG
• Contrel Europe
• Durbin
• Gima SpA
• HLL Lifecare Limited
• Meril Life Sciences Pvt. Ltd
• Mona Lisa NV

結論和建議

Global Intrauterine Devices Market size was valued at USD 3.12 billion in 2022 and is poised to grow from USD 3.23 billion in 2023 to USD 4.36 billion by 2031, growing at a CAGR of 3.8% during the forecast period (2024-2031).

The intrauterine devices (IUD) market is witnessing significant growth driven by increasing rates of unplanned pregnancies, unsafe abortions, and heightened awareness of contraceptive options. To support this demand, government initiatives and advancements in research and development are fostering the creation of innovative IUDs. In the U.S., the trend towards planned delayed pregnancies complements this upward trajectory, as the government promotes better access to sexual and reproductive health services. However, challenges such as insufficient awareness of IUDs, potential side effects, and early removals hinder market expansion. Despite these obstacles, emerging economies are showing promising opportunities for market players due to rising disposable incomes and a growing demand for healthy lifestyles. Continued innovations and regulatory support are anticipated to further propel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Devices Market Segmental Analysis

Global Intrauterine Devices Market is segmented by Type, by Age Group, by Distribution Channel, by End User and by Region. Based on Type, the market is segmented into Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing. Based on Age Group, the market is segmented into 25-34 years, 35-44 years, Above 44 years, 15-24 years. Based on Distribution Channel, the market is segmented into Hospital, Gynecology Clinics, Community Health Care Centers, and Others. Based on End User, the market is segmented into Hospitals, Clinics, Community Health Care Centres, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Global Intrauterine Devices Market

The global intrauterine devices market is significantly driven by the rising awareness and acceptance of contraception. As public understanding of family planning's importance grows, so does the recognition of effective contraceptive methods, particularly long-term solutions like intrauterine devices (IUDs). This heightened awareness among individuals and healthcare professionals regarding the advantages of IUDs has led to an increased demand for these devices. Consequently, the emphasis on effective birth control options is propelling the market forward, reflecting a broader trend in society towards informed reproductive health choices and greater accessibility to reliable contraceptive methods.

Restraints in the Global Intrauterine Devices Market

The Global Intrauterine Devices market faces significant constraints due to stringent regulatory requirements. As medical devices, intrauterine devices must adhere to rigorous safety and effectiveness standards imposed by regulatory authorities. This landscape can create considerable challenges for manufacturers, making it difficult for them to meet compliance benchmarks, secure necessary approvals, and navigate the complex regulatory environment. Consequently, these stringent regulations may deter new entrants from entering the market, ultimately restricting the growth potential of the intrauterine devices sector. As a result, the combination of regulatory hurdles and compliance demands presents a notable obstacle to market expansion.

Market Trends of the Global Intrauterine Devices Market

The global Intrauterine Devices (IUDs) market is experiencing significant growth, driven by the rising incidence of unplanned pregnancies and increasing acceptance of IUDs as effective contraceptive options. Hormonal IUDs are gaining popularity, not only for their contraceptive benefits but also for their ability to manage menstrual issues, including severe cramps and heavy bleeding. Awareness initiatives by health organizations are further enhancing consumer education on family planning and the negative health impacts of unintended pregnancies. Moreover, the expanding demographic appeal of IUDs to nulliparous women and adolescents underscores a shift in contraceptive preferences, positioning the market for substantial long-term expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Intrauterine Devices Market Size by Type & CAGR (2024-2031)

• Nonhormonal: Copper-containing IUD
• Hormonal: Progestogen-releasing IUD

Global Intrauterine Devices Market Size by Age Group & CAGR (2024-2031)

• 25-34 years
• 35-44 years
• Above 44 years
• 15-24 years

Global Intrauterine Devices Market Size by Distribution Channel & CAGR (2024-2031)

• Hospital
• Gynecology Clinics
• Community Health Care Centers
• Others

Global Intrauterine Devices Market Size by End User & CAGR (2024-2031)

• Hospitals
• Clinics
• Community Health Care Centres
• Others

Global Intrauterine Devices Market Size by Region & CAGR (2024-2031)

• North America, (by Type, by Age Group, by Distribution Channel, by End User)
  • US
  • Canada
• Europe, (by Type, by Age Group, by Distribution Channel, by End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (by Type, by Age Group, by Distribution Channel, by End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (by Type, by Age Group, by Distribution Channel, by End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (by Type, by Age Group, by Distribution Channel, by End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROGINE, S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mona Lisa N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCON Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prosan International BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMB Corporation of India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANI Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan NV (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melbea AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contrel Europe
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Durbin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gima S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mona Lisa N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation